Patent Assignment
Reel/Frame 073559/0435
Assignment of Assignor's Interest
Recorded: 2026-01-23
Pages: 20
Assignor
AKAMIS BIO LIMITED
Executed: 2025-12-22
Assignee
AKAMIS BIO, INC.
245 MAIN STREET, 2ND FLOOR, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(35)
Chimeric Adenoviruses for Use in Cancer Treatment
Chimeric Adenoviruses for Use in Cancer Treatment
Chimeric Adenoviruses for Use in Cancer Treatment
Chimeric Adenoviruses for Use in Cancer Treatment
Chimeric Adenoviruses for Use in Cancer Treatment
Chimeric Adenoviruses for Use in Cancer Treatment
Chimeric adenoviruses for use in cancer treatment
Application:
60/574,851 →
A Dosing Regime and Formulations for Type B Adenovirus
Dosing Regime and Formulations for Type B Adenoviruses
Dosing Regime and Formulations for Type B Adenoviruses
Application:
19/237,875 →
Publication:
US US20260216263A1
A Method of Making Adenovirus and Corresponding Plasmids
Oncolytic Adenoviruses Armed with Heterologous Genes
Oncolytic Adenoviruses Armed with Heterologous Genes
Oncolytic Adenoviruses Armed with Heterologous Genes
Oncolytic Adenoviruses Armed with Heterologous Genes
Group B Adenovirus Modified in the E4ORF4 Region
Oncolytic Adenovirus Encoding a B7 Protein
Oncolytic Adenovirus Encoding a B7 Protein or Active Fragment
Oncolytic Adenovirus Encoding a B7 Protein or Active Fragment
Oncolytic Adenovirus Encoding a Therapeutic Protein or Active Fragment
Oncolytic Adenovirus Encoding a B7 Protein
Virus Encoding an Anti-Tcr-Complex Antibody or Fragment
Oncolytic Group B Adenovirus Expressing a Stroma-Targeted Bispecific T-Cell Engager
Adenovirus Armed with Bispecific T Cell Activator
Application:
18/744,059 →
Publication:
US US20250026851A1
Adenovirus Armed with Bispecific T Cell Engager
Group B Adenovirus Encoding an Anti-Tcr-Complex Antibody or Fragment
Group B Adenovirus Encoding an Anti-Tcr-Complex Antibody or Fragment
Application:
18/520,030 →
Publication:
US US20240247061A1
Oncolytic Virus and Method
Group B Adenovirus-Containing Formulation
Group B Adenovirus-Containing Formulation
Method of Purifying a Composition Comprising a Group B Adenovirus
Application:
17/596,717 →
Publication:
US US20220340885A1
Adenovirus Armed with Bispecific T Cell Activator
Adenovirus armed with bispecific T cell activator
Application:
18/481,833 →
Publication:
US US20240175052A1
Adenovirus Encoding Il-15
Application:
18/546,357 →
Publication:
US US20240180983A1
Virus Encoding Transgenes to Complement Cellular Therapy
Application:
19/035,441 →
Publication:
US US20250269012A1
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 18, 2005
From: HARDEN, PAUL; HEMISTON, TERRY; KUHN, IRENE
To: SCHERING AKTIENGESELLSHAFT
Reel/Frame 016419/0305 →
Change of Name
Aug 20, 2008
From: SCHERING AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 021411/0374 →
Assignment of Assignor's Interest
Feb 18, 2011
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: HYBRID BIOSYSTEMS LTD.
Reel/Frame 025830/0722 →
Assignment of Assignor's Interest
May 18, 2011
From: HYBRID BIOSYSTEMS LIMITED
To: PSIOXUS THERAPEUTICS LIMITED
Reel/Frame 026298/0762 →
Assignment of Assignor's Interest
Jul 26, 2012
From: HARDEN, PAUL; HERMISTON, TERRY; KUHN, IRENE
To: SCHERING AKTIENGESELLSCHAFT
Reel/Frame 028641/0336 →
Assignment of Assignor's Interest
Jul 26, 2012
From: HYBRID BIOSYSTEMS LIMITED
To: PSIOXUS THERAPEUTICS LIMITED
Reel/Frame 028643/0894 →
Assignment of Assignor's Interest
Jul 26, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: HYBRID BIOSYSTEMS LIMITED
Reel/Frame 028641/0858 →
Change of Name
Jul 26, 2012
From: SCHERING AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 028641/0806 →
Assignment of Assignor's Interest
Mar 15, 2013
From: HARDEN, PAUL; HERMISTON, TERRY; KUHN, IRENE
To: SCHERING AKTIENGESELLSCHAFT
Reel/Frame 030009/0275 →
Assignment of Assignor's Interest
Mar 15, 2013
From: HYBRID BIOSYSTEMS LIMITED
To: PSIOXUS THERAPEUTICS LIMITED
Reel/Frame 030018/0907 →
Change of Name
Mar 15, 2013
From: SCHERING AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030018/0837 →
Assignment of Assignor's Interest
Mar 15, 2013
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: HYBRID BIOSYSTEMS LIMITED
Reel/Frame 030018/0193 →
Assignment of Assignor's Interest
Apr 17, 2013
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: HYBRID BIOSYSTEMS LIMITED
Reel/Frame 030230/0777 →
Change of Name
Apr 17, 2013
From: SCHERING AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030230/0836 →
Assignment of Assignor's Interest
Apr 17, 2013
From: HYBRID BIOSYSTEMS LIMITED
To: PSIOXUS THERAPEUTICS LIMITED
Reel/Frame 030230/0819 →
Assignment of Assignor's Interest
Apr 17, 2013
From: HARDEN, PAUL; HERMISTON, TERRY; KUHN, IRENE
To: SCHERING AKTIENGESELLSCHAFT
Reel/Frame 030230/0685 →
Assignment of Assignor's Interest
Aug 20, 2014
From: HARDEN, PAUL; HERMISTON, TERRY; KUHN, IRENE
To: SCHERING AKTIENGESELLSCHAFT
Reel/Frame 033575/0141 →
Assignment of Assignor's Interest
Aug 20, 2014
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: HYBRID BIOSYSTEMS LIMITED
Reel/Frame 033575/0197 →
Change of Name
Aug 20, 2014
From: SCHERING AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 033577/0600 →
Assignment of Assignor's Interest
Aug 21, 2014
From: HYBRID BIOSYSTEMS LIMITED
To: PSIOXUS THERAPEUTICS LIMITED
Reel/Frame 033578/0751 →
Assignment of Assignor's Interest
Apr 6, 2016
From: BEADLE, JOHN WILLIAM; FISHER, KERRY; WILKINSON BLANC, CHRISTINE
To: PSIOXUS THERAPEUTICS LIMITED
Reel/Frame 038209/0597 →
Assignment of Assignor's Interest
Jul 20, 2016
From: CHAMPION, BRIAN ROBERT; BROWN, ALICE CLAIRE NOEL; FISHER, KERRY DAVID; NICOLSON, TAMARA
To: PSIOXUS THERAPEUTICS LIMITED
Reel/Frame 039203/0609 →
Assignment of Assignor's Interest
Aug 15, 2016
From: HARDEN, PAUL; HERMISTON, TERRY; KUHN, IRENE
To: SCHERING AKTIENGESELLSCHAFT
Reel/Frame 039436/0161 →
Change of Name
Aug 15, 2016
From: SCHERING AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 039685/0966 →
Assignment of Assignor's Interest
Oct 17, 2016
From: CHAMPION, BRIAN ROBERT; BROWN, ALICE CLAIRE NOEL
To: PSIOXUS THERAPEUTICS LIMITED
Reel/Frame 040035/0088 →